~~<i id='CBB4CBBA96'><strike id='CBB4CBBA96'><tt id='CBB4CBBA96'><pre id='CBB4CBBA96'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：fashion 2025-09-30 11:44:19 Page View：5927

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul
Next article： Affirmative action in medical school literally saved lives

explore

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

Men with early prostate cancer can safely opt out of treatment

AnMRIscanoftheprostate.MichaelOhliger/UCSFMendiagnosedwithearlyprostatecancercansafelychooseactivemo

Trump demands the U.S. pay no more for drugs than other countries … again

EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

Sophia Smith scores twice for US in in 3

UnitedStates'AlexMorgan(13)andSavannahDeMelo(9)celebrateagoalbyteammateSophiaSmithduringthefirsthalf